Related Experiment Video
Updated: Feb 10, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Emerging Cellular Therapies for Glioblastoma Multiforme
Paul J Choi1, R Shane Tubbs2, Rod J Oskouian3
1Clinical Anatomy, Seattle Science Foundation.
Abstract:
Glioblastoma multiforme (GBM) is the most common type of malignant primary brain cancer in adults. It is composed of highly malignant cells that display metastatic and angiogenic characteristics, making it resistant to current first-line chemotherapy with temozolomide, an alkylating agent. Despite many years of research, GBM remains poorly responsive to multiple available therapies, giving GBM patients, who receive the conventional combination of chemoradiotherapies and surgical resection, a dismal prognosis. There is growing evidence that the conventional systemic chemotherapeutic agents for GBM are ineffective in improving the disease progression. We aim to explore the emerging cellular therapies which may play a significant role in treating GBM.
More Related Videos
Related Concept Videos
Emerging Adulthood
Introduction Cardiac Emergencies
Gene Therapy
Applications of GIS: Disaster Management and Emergency Response
Group Therapy
Cellular Differentiation
A zygote is a...

